Hyperfine Inc.

03/31/2025 | Press release | Archived content

Eagle Pharmaceuticals Announces $69 Million Agreement to Monetize BENDEKA® Royalties

Read this content
Click here to read the original version at the source's official website. The text of this article is not available at the moment.
Hyperfine Inc. published this content on March 31, 2025, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on April 03, 2025 at 18:14 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]